In this editor's desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what's still to be done.
BD and Biocorp joined forces to improve the outcomes and adherence of self-administered drugs through connected drug delivery, by combining the use of digital technology with prefillable syringes.
In this case study, Zambon worked extensively to redefine the product profile due to the introduction of new raw material suppliers, with the concurrent aim to achieve an improvement of PSD with minimisation of fines and big agglomerates.
Lonza's Giovanna Libralon, Small Molecules, and Iwan Bertholjotti, Bioconjugates, share insights on payload-linker manufacturing and the global market trends for ADC-based therapies, along with the antibodies that help increase the precision of ADCs.
Airnov Healthcare Packaging, a specialist in controlled atmosphere packaging, has surpassed five years of manufacturing at its production facility in India, and announces it participation to CPhI India 2022.
Rebekah Jordan talks with Peter Shone, chief technology officer, iethico, about its latest AI-powered platform that can give clear indications of medicine shortages and predict future supply chain challenges - and what this means for pharmacists.
EPM held a Q&A session with Vincent Rolland, Idorsia Pharmaceuticals, and Richard Young, Veeva, to discuss how investing in digital data management can benefit biopharma, from clinical trials through to market.
Rebekah Jordan sat down with Lynn Durham, CEO & founder of STALICLA, to discuss STALICLA’s recent partnership with Evgen Pharma that aims bring a therapeutic option to currently underserved patients with neurodevelopmental disorders (NDDs).
Particle Works launches its second platform, the Automated Library Synthesis (ALiS) System, enabling automation and high-throughput screening of lipid nanoparticle (LNP) formulations and mRNA candidates in early-stage drug development.
Birmingham Biotech, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, launches NoriZite Nasal Spray, an easy-to-use nasal device designed to block and trap inhaled virus particles, into the UK market.
LLS Health's experts, Joey Glassco, MBA, Injectable Drug Delivery, and Nick DiFranco, MEM, global market segment manager, share the API solubility puzzle that the pharma industry faces and how to solve it.
Lisa Caralli, Science and Technology director, Pharmaceutics, Catalent, discusses the methods that formulation scientists can undertake on small quantities of API to achieve the greatest possible results to progress through drug product development.
